Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lingzhi in Untreated Early Parkinson's Disease
NCT03594656Phase 3Unknown
- Sponsor
- Xuanwu Hospital
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 3 trial of ganoderma lucidum in Parkinson's disease (PD), sponsored by Xuanwu Hospital. Status: unknown.
02
Drugs
ganoderma lucidum
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03594656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03594656.